Figure 5: Conolidine is antinociceptive in visceral, tonic and persistent soreness models and is also existing at micromolar concentrations while in the brain right after systemic injection. Conolidine CONOCB2™ effectively operates by making a barrier in between the opioid receptors while in the brain along with the "scavenger" receptors https://maximp258qmh7.tokka-blog.com/profile